AXA IM’s ETF platform turns three: Flagship NASDAQ 100 UCITS ETF reaches key anniversary milestone
KEY POINTS
Three years ago, the NASDAQ Index presented a natural choice to expand AXA IM’s presence in the ETF marketplace. What could be a more complementary partnership aiding our mission to continuously serve our clients’ evolving needs, than an index long recognised as standing at the forefront of pioneering, technological progress – the ‘index of innovation’?
In November 2022, AXA IM launched the AXA IM NASDAQ 100 UCITS ETF (ANAU), a passively managed ETF that seeks to replicate the Nasdaq-100 Index® as closely as possible – with a low tracking error of 4bps since launch.3Past performance is not a reliable indicator of future results. This flagship product, then and now, is designed to combine the strength of our investment expertise heritage with a liquid, accessible and straightforward way for our clients to gain differentiated US large-cap equity exposure to suit their investment goals. 4
With a total expense ratio (TER) of 14bps*, the ANAU ETF continues to establish its credentials as a cost-effective way for clients to participate in what we believe are the most promising, disruptive long-term technology investment themes.5 Indeed, the NASDAQ is home to the top five companies that spent the most on research and development during 2024, repeating the trend of previous years.6
- Source : AXA IM, Factset, Bloomberg, USD Share Class, as at 31/10/2025. Performance is based on the reinvestment of dividends and presented net of financial management fees excluding any others management expenses, hedging currency costs, social contribution and tax costs. *Benchmark: The prospectus benchmark of this ETF has evolved on 03/02/2025. Since that date, the NASDAQ-100 Notional Net Total Return Index is used. Before this date (from ETF launch on 16/11/2022 to 03/02/2025), the benchmark was the NASDAQ 100 Total Return Index.
- {https://www.nasdaq.com/solutions/global-indexes/nasdaq-100;Nasdaq-100 Index}
- Source: AXA Investment Managers as of 12th of November 2025. Given for informational purposes only.
- {https://www.statista.com/statistics/265645/ranking-of-the-companies-with-the-highest-spending-on-research-and-development/;Ranking of the companies with the highest spending on research and development worldwide in 2024}
The seismic effects of artificial intelligence (AI) on global markets continue to build apace as we approach the end of the year and beyond. 2025’s projected market size of $254.5bn is expected to grow to a volume of $1.68tn by 2031 – an estimated compound annual growth rate (CAGR) of 36.98%.7 Behind these impressive headlines, however, lies a spectrum of companies; these range from those emerging AI innovators for whom investor enthusiasm counts as one of their strongest assets, all the way through to the established ‘Magnificent Seven’ companies (Alphabet (Google), Amazon, Apple, Meta Platforms, Microsoft, NVIDIA and Tesla) with a track record of strong fundamentals and profitability.8 Seasoned investors who may have weathered shifting technology-related market sentiments in the past will no doubt recognise the appeal of adding larger, proven, AI-exposed companies to their portfolio.
Our NASDAQ ETF not only provides this exposure but does so in one swift transaction – the simplicity, ease and liquidity profile of this fund offers a sharp contrast to the sophisticated and diverse range of growth opportunities found packaged within. The NASDAQ hosts many leading, prominent and boundary-breaking global technology companies, offering diversified exposure to the AI theme across semiconductors, software, and cloud computing.
Our belief that AI is reaching an inflection point persists, with many NASDAQ companies outside of technology well positioned to benefit from surging demand in AI-driven solutions across manufacturing, healthcare, agriculture, energy management, transportation, and more.
- {https://www.statista.com/outlook/tmo/artificial-intelligence/worldwide?srsltid=AfmBOoruqBH8qNBceXwHc1RSr_UDqLRNdOrRdfpkxN0r_KFn5g8D1CgQ;Artificial Intelligence - Worldwide}
- {https://www.theaic.co.uk/aic/news/press-releases/managers-comment-on-whether-ai-is-driving-a-stock-market-bubble;Managers comment on whether AI is driving a stock market bubble}
With its structural advantage in high-growth themes, the NASDAQ remains, in our view, an unmatched opportunity for investors seeking exposure to the future of innovation. The subsequent launches of our hedged share classes in euros and Mexican pesos demonstrate further our commitment to align ourselves with our global clients’ needs.
Investors with a keen interest in the ETF market will no doubt have noticed the momentum with which AXA IM continued to add to our ETF product suite during the past three years. Following the success of the launch of ANAU, as of December 2025 we now offer 17 ETF products across equity and fixed income indices, including two actively managed products.
With this in mind, we look forward to continuing to anticipate and fulfil the investment needs of our clients in 2026 and beyond, particularly as our integration into the BNP Paribas AM family progresses. Those same ETF investors with a keen eye on the markets will likely not have missed their ongoing high-profile ETF launches and dedication to growing these capabilities, most recently augmenting their presence within the UK with the listing of 14 of their strategies on the London Stock Exchange.9
In a rapidly evolving global marketplace, ETFs tracking indices such as the NASDAQ can help investors pair an appetite for innovation-backed growth with the parameters of their exposure, liquidity and risk management demands. As AXA IM and BNP Paribas AM step into the future together, we trust that our clients, both present and future, will benefit from our enthusiasm to discover how the combination of two established ETF providers can best serve their requirements.
- {https://citywire.com/wealth-manager/news/bnp-paribas-targets-defence-and-active-demand-with-14-etf-launch/a2477669;BNP Paribas targets defence and active demand with 14 ETF launch}
| Primary Exchange Ticker | ISIN | Shareclass | Trading Currency | Exchange | *TER |
| ANAU GY | IE000QDFFK00 | USD Acc | USD | Xetra | 0.14% |
| ANAE IM | IE000STJ19F2 | EUR (H) Acc | EUR | Borsa Italiana | 0.20% |
| ANAMN MU | IE000HN2PIB9 | MXN (H) Acc | MXN | BIVA | 0.20% |
Source: AXA IM as at 30/11/2025.
The investment will be reduced by the payment of the below costs/fees – ACC USD:
For all clients, on the secondary market:
Transaction costs occur when purchasing/selling ETF shares on the market and may be subject to broker fees and/or other charges. Only Authorized participants can deal directly with the Fund.
For Authorised Participants (AP), on the primary market:
Redemption Fee : Up to 3%.
Subscription Fee : Up to 3%.
This is the maximum that might be taken out of your money before it is invested. Entry and exit charges are not applicable to investors buying/selling shares of the Fund on stock exchanges, but these investors will do so at market prices and may be subject to broker fees and/or other charges.
Charges taken from the fund under specific conditions:
Performance Fees – None
Minimum initial and subsequent subscription:
Minimum initial subscription 1 share on secondary market - 150 000 for the AP
Subsequent subscription 1 share on secondary market - 150 000 for the AP
Disclaimer
Key Risks:
The list below of risk factors is not exhaustive. Please refer to the prospectus & prospectus supplement for full product details and complete information on the risks.
Equity Risk: the value of shares in which a Fund invests fluctuate pursuant to market expectations. The value of such shares will go up and down and equity markets have historically been more volatile than fixed interest markets. Should the price of shares in which the Fund has invested fall, the Net Asset Value of the Fund will also fall. Funds investing in shares are generally more volatile than funds investing in bonds or a combination of shares and bonds but may also achieve greater returns.
Capital Loss: An investment in a Fund involves investment risks, including possible loss of the amount invested. Investors may lose part of or entirely the invested capital depending on market conditions.
Impact of any techniques such as derivatives: Certain management strategies involve specific risks, such as liquidity risk, credit risk, counterparty risk, legal risk, valuation risk, operational risk and risks related to the underlying assets. The use of such strategies may also involve leverage, which may increase the effect of market movements on the Fund and may result in significant risk of losses.
Sustainability risks: The Fund does not integrate sustainability risks. Taking into account the investment objective and strategy of the Fund, the Investment Manager does not consider the principal adverse impacts in its investment decisions since it does not intend to promote environmental or social characteristics nor to have a sustainable investment objective. In addition, the principal adverse impacts are not considered as the fund’s strategy consists in tracking its reference Index.
Not for Retail distribution: This marketing communication is intended exclusively for Professional, Institutional or Wholesale Clients / Investors only, as defined by applicable local laws and regulation. Circulation must be restricted accordingly.
This marketing communication does not constitute on the part of AXA Investment Managers a solicitation or investment, legal or tax advice. This material does not contain sufficient information to support an investment decision.
Due to its simplification, this document is partial and opinions, estimates and forecasts herein are subjective and subject to change without notice. There is no guarantee forecasts made will come to pass. Data, figures, declarations, analysis, predictions and other information in this document is provided based on our state of knowledge at the time of creation of this document. Whilst every care is taken, no representation or warranty (including liability towards third parties), express or implied, is made as to the accuracy, reliability or completeness of the information contained herein. Reliance upon information in this material is at the sole discretion of the recipient. This material does not contain sufficient information to support an investment decision.
Before making an investment, investors should read the relevant Prospectus and the Key Investor Information Document / scheme documents, which provide full product details including investment charges and risks. The information contained herein is not a substitute for those documents or for professional external advice.
The products or strategies discussed in this document may not be registered nor available in your jurisdiction. Please check on the local web sites (available here: https://funds.axa-im.com/), where the funds and share classes published are filtered according to country of registration and investors’ profile. In particular units of the funds may not be offered, sold or delivered to U.S. Persons within the meaning of Regulation S of the U.S. Securities Act of 1933. The tax treatment relating to the holding, acquisition or disposal of shares or units in the fund depends on each investor’s tax status or treatment and may be subject to change. Any potential investor is strongly encouraged to seek advice from its own tax advisors.
For more information on sustainability-related aspects please visit: https://www.axa-im.com/important-information/sfdr
For investors located in the European Union :
Please note that the management company reserves the right, at any time, to no longer market the product(s) mentioned in this communication in the European Union by filing a notification to its supervision authority, in accordance with European passport rules.
In the event of dissatisfaction with AXA Investment Managers products or services, you have the right to make a complaint, either with the marketer or directly with the management company (more information on AXA IM complaints policy is available in English: https://www.axa-im.com/important-information/comments-and-complaints ). If you reside in one of the European Union countries, you also have the right to take legal or extra-judicial action at any time. The list of consumer dispute resolution entities in the Member States, Norway and Iceland and their contract data is available here: https://consumer-redress.ec.europa.eu/dispute-resolution-bodies and information on available means of redress are available at: https://consumer-redress.ec.europa.eu/index_en
Summary of investor rights in English is available on AXA IM website https://www.axa-im.com/important-information/summary-investor-rights
Translations into other languages are available on local AXA IM entities’ websites.
AXA IM NASDAQ 100 UCITS ETF is a sub-fund(s) of the Irish-domiciled ICAV AXA IM ETF with registered address at 33 Sir John Rogerson’s Quay, Dublin 2, Ireland, and registered with the Central Bank of Ireland under the number C469468. AXA IM ETF ICAV is a collective asset-management vehicle under the European UCITS directive. It is managed by AXA Investment Managers Paris, a company incorporated under the laws of France, having its registered office located at Tour Majunga, 6 place de la Pyramide, 92800 Puteaux, registered with the Nanterre Trade and Companies Register under number 353 534 506, and a Portfolio Management Company, holder of AMF approval no. GP 92008, issued on 7 April 1992.
Nasdaq®, Nasdaq-100 Index ®, NDX ®, Nasdaq-100® are registered trademarks of Nasdaq, Inc. (which with its affiliates is referred to as the “Corporations”) and are licensed for use by AXA Investment Managers Paris. The Product(s) have not been passed on by the Corporations as to their legality or suitability. The Product(s) are not issued, endorsed, sold, or promoted by the Corporations. THE CORPORATIONS MAKE NO WARRANTIES AND BEAR NO LIABILITY WITH RESPECT TO THE PRODUCT(S).
UCITS ETF’s units / shares purchased on the secondary market cannot usually be sold directly back UCITS ETF. Investors must buy and sell units / shares on a secondary market with the assistance of an intermediary (e.g. a stockbroker) and may incur fees for doing so. In addition, investors may pay more than the current net asset value when buying units / shares and may receive less than the current net asset value when selling them.
Past performance is not a guide to current or future performance, and any performance or return data displayed does not take into account commissions and costs incurred when issuing or redeeming units. References to league tables and awards are not an indicator of future performance or places in league tables or awards and should not be construed as an endorsement of any AXA IM company or their products or services. Please refer to the websites of the sponsors/issuers for information regarding the criteria on which the awards/ratings are based. The value of investments, and the income from them, can fall as well as rise and investors may not get back the amount originally invested. Exchange-rate fluctuations may also affect the value of their investment. Due to this and the initial charge that is usually made, an investment is not usually suitable as a short term holding.
Issued in the UK by AXA Investment Managers UK Limited, which is authorised and regulated by the Financial Conduct Authority in the UK. Registered in England and Wales No: 01431068. Registered Office: 22 Bishopsgate London EC2N 4BQ
In other jurisdictions, this document is issued by AXA Investment Managers SA’s affiliates in those countries.
Austria: The current prospectus of the fund AXA IM NASDAQ 100 UCITS ETF as well as the current respective key information document for packaged retail and insurance-based investment products (“PRIIP”) were published in electronic form on www.axa-im.at on October 2025 and by deposition at AXA Investment Managers Deutschland GmbH, Thurn-und-Taxis-Platz 6, 60313 Frankfurt am Main. Investors and interested persons in Austria receive the respective prospectus in English, the respective key information document for packaged retail and insurance-based investment products (“PRIIP”) in German in paper form, the respective fund rules (Fondsbestimmungen) and the respective annual and semi-annual report of the AXA IM NASDAQ 100 UCITS ETF free of charge at AXA Investment Managers Deutschland GmbH and on www.axa-im.at. There further information and documents regarding the product may be examined . The issue prices and redemption prices are also available at there and on www.axa-im.at. At State Street Fund Services (Ireland) Limited, 78 Sir John Rogerson’s Quay, Dublin 2, Ireland the subscription-, payment-, repurchase- and redemption orders may be submitted. At the AXA Investment Managers Deutschland GmbH as well as at www.axa-im.de/rechtliche-hinweise a summary of information on investor rights is available upon request in German language. The company managing the respective fund may discontinue further distribution of the fund.
Denmark, Finland, Norway, Sweden: The current prospectus of the fund AXA IM NASDAQ 100 UCITS ETF as well as the current respective key information document for packaged retail and insurance-based investment products (“PRIIP”) are published in electronic form on https://nordics.axa-im.com/ on October 2025 and by deposition at AXA Investment Managers Deutschland GmbH, Thurn-und-Taxis-Platz 6, 60313 Frankfurt am Main. Investors and interested persons receive the respective prospectus in English, the respective key information document for packaged retail and insurance-based investment products (“PRIIP”) in national language in paper form, the respective fund rules and the respective annual and semi-annual report of the AXA IM NASDAQ 100 UCITS ETF free of charge at AXA Investment Managers Deutschland GmbH and on https://nordics.axa-im.com/. There further information and documents regarding the product may be examined. At State Street Fund Services (Ireland) Limited, 78 Sir John Rogerson’s Quay, Dublin 2, Ireland the subscription-, payment-, repurchase- and redemption orders may be submitted. The issue prices and redemption prices are available at this information and paying agent and on https://nordics.axa-im.com/. At the AXA Investment Managers Deutschland GmbH as well as at www.axa-im.de/rechtliche-hinweise a summary of information on investor rights is available upon request in German language. The company managing the respective fund may discontinue further distribution of the fund.
France: Issued by AXA INVESTMENT MANAGERS PARIS, a company incorporated under the laws of France, having its registered office located at Tour Majunga, 6 place de la Pyramide, 92800 Puteaux, registered with the Nanterre Trade and Companies Register under number 353 534 506, and a Portfolio Management Company, holder of AMF approval no. GP 92-08, issued on 7 April 1992.
Germany: For professional clients only. Not for retail investors
This is promotional material, not a regular mandatory document and is not suitable for any kind of sales services, consulting or financial services vis-à-vis retail clients. The information in this document is exclusively addressed to professional clients who receive this document directly from AXA Investment Managers Deutschland GmbH / its affiliated companies. It is to be treated strictly confidential. The recipients are not allowed to pass this document and the information contained herein on to a third party, in whole or in part, without the prior written consent of AXA Investment Managers Deutschland GmbH / its affiliated companies.
You will receive the respective prospectus in English, respective key information document for packaged retail and insurance-based investment products (“PRIIP”) in your national language in paper form and the respective annual and semi-annual report upon request free of charge and in paper form at AXA Investment Managers Deutschland GmbH • Thurn-und-Taxis-Platz 6 • 60313 Frankfurt/Main or from our distribution partners or under www.axa-im.de. At the AXA Investment Managers Deutschland GmbH as well as at www.axa-im.de/rechtliche-hinweise a summary of information on investor rights is available upon request in German language. At State Street Fund Services (Ireland) Limited, 78 Sir John Rogerson’s Quay, Dublin 2, Ireland the subscription-, payment-, repurchase- and redemption orders may be submitted.]The company managing the respective fund may discontinue further distribution of the fund.
Italy: This document is intended for informational purposes only, and in no event is intended for retail customers and/or end investors. The information contained herein is for professional clients and eligible counterparties as defined by local laws and the MIFID directive, it is presumed, therefore, experience, knowledge and expertise to make their own investment decisions and properly assess their risks.
Liechtenstein: Information for Investors and interested persons in the Principality of Liechtenstein: Investors and interested persons in the Principality of Liechtenstein receive the current prospectus in English, the current key information document for packaged retail and insurance-based investment products (“PRIIP”) in German language in paper form, the respective annual and semi-annual report of the AXA IM NASDAQ 100 UCITS ETF free of charge at AXA Investment Managers Deutschland GmbH, Thurn-und-Taxis-Platz 6, 60313 Frankfurt am Main or in electronic form on www.axa-im.li. At At State Street Fund Services (Ireland) Limited, 78 Sir John Rogerson’s Quay, Dublin 2, Ireland the subscription-, payment-, repurchase- and redemption orders may be submitted. At the AXA Investment Managers Deutschland GmbH as well as at www.axa-im.de/rechtliche-hinweise a summary of information on investor rights is available upon request in German language. The company managing the respective fund may discontinue further distribution of the fund.
Luxembourg: In Luxembourg, this document is intended for Professional Clients only, as defined by local laws and the MIFID directive, and is distributed by AXA IM Benelux SA/NV, 1 Place du Trône – 1000 Brussels Belgium.
Netherlands: In the Netherlands, this document is intended for Professional Clients only, as defined by local laws and the MIFID directive, and is distributed by AXA IM Paris - Netherlands Branch, Beethoven 500 – 4th Floor, Beethovenstraat 518 – 1082 PR Amsterdam - the Netherlands. AXA Investment Managers Paris is a company incorporated under the laws of France, having its registered office located at Tour Majunga, 6 place de la Pyramide, 92800 Puteaux, registered with the Nanterre Trade and Companies Register under number 353 534 506, and a Portfolio Management Company, holder of AMF approval no. GP 92-08, issued on 7 April 1992.
Portugal: In Portugal, this document is distributed by AXA Investment Managers Paris, Sucursal en España, has its registered office in Madrid, Paseo de la Castellana no. 93, 6th floor, is registered in the Madrid Mercantile Register, sheet H-727252, and is registered with the CNMV under 38 number as UCITS management company of the European Economic Space, with Branch.
Spain: This document is intended for informational purposes only, and in no event is intended for retail customers and/or end investors. The information contained herein is for professional clients and eligible counterparties as established in articles 194 and 196 of the consolidated text of Law 6/2023 of 17 March on the Securities Markets and Investment Services (Ley del Mercado del Valores y de los Servicios de Inversión), it is presumed, therefore, experience, knowledge and expertise to make their own investment decisions and properly assess their risks.
Switzerland: In Switzerland, this document is intended for professional investors according to Swiss law only. It is distributed by AXA Investment Managers Switzerland Ltd, Ernst-Nobs-Platz 7, CH-8004 Zurich (Postal address: P.O. Box 1078, CH-8021 Zurich). The Swiss representative for the Ireland-domiciled ICAV (Irish Collective Asset Management Vehicle) AXA IM ETF ICAV, is FIRST INDEPENDENT FUND SERVICES LTD. (FIFS), Feldeggstrasse 12, CH-8008 Zurich. The Swiss paying agent is NPB New Private Bank Ltd, Limmatquai 1, PO Box, CH-8001 Zurich. The current prospectus, the Key Information Document (PRIIPs KID), the instrument of incorporation as well as the annual and semi-annual reports can be obtained free of charge from the Swiss representative. In respect of the units offered in Switzerland, the place of performance is the registered office of the Swiss representative. The place of jurisdiction is at the registered office of the Swiss representative or at the registered office or place of residence of the investor.
UK: The fund is recognised by the UK Financial Conduct Authority and is available for sale in the UK.